Form 4: Nkarta Director Leone Patterson Granted 46,000 Stock Options

Nkarta, Inc. Director Leone Patterson was granted 46,000 stock options with an exercise price of $1.83, vesting fully by June 5, 2026, or earlier under certain conditions.

Summary

• Leone D. Patterson, a Director of Nkarta, Inc. (NKTX), was granted 46,000 stock options.
• The transaction date for the option grant was June 5, 2025.
• The exercise price for these stock options is $1.83 per share.
• The options are for 46,000 shares of Common Stock.
• All shares subject to the option vest 100% on the first to occur of (i) June 5, 2026, or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders after the grant date.
• The options have an expiration date of June 4, 2035.
• Full vesting will also occur upon a 'change in control' of Nkarta, Inc. or upon the Reporting Person's separation from service due to death or 'disability'.
• The filing was signed by Bridgette Housley as Attorney-in-Fact for Leone Patterson on June 9, 2025.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as the grant of stock options to a director aligns their interests with shareholders and serves as an incentive for long-term performance, which is generally viewed favorably. It is a routine compensation event.

Positives

• The grant of stock options to Director Leone Patterson aligns her interests with those of shareholders, incentivizing long-term performance and retention.
• The vesting schedule, including accelerated vesting upon change of control or certain separation events, provides clear incentives and protections for the director.

Future Outlook

The document details the vesting schedule for the granted stock options, indicating that all shares will vest 100% on the first to occur of June 5, 2026, or the day immediately preceding the first annual meeting of the Issuer's stockholders after the grant date. Additionally, full vesting is triggered by a 'change in control' or the reporting person's separation due to death or 'disability'.

Industry Context

The granting of stock options to directors is a common practice in the biotechnology and pharmaceutical industries, including companies like Nkarta, Inc., to attract and retain talent, align management and board interests with shareholder value, and incentivize long-term strategic performance. This specific filing reflects a routine compensation event for a director.

Corporate Governance

Related Party Transactions

• The grant of 46,000 stock options to Leone D. Patterson, a Director of Nkarta, Inc., constitutes a related party transaction as it involves compensation to an insider.

Stakeholder Impact

• Shareholders: The grant of stock options to a director aims to align the director's financial interests with shareholder value creation, potentially leading to better long-term performance.
• Employees: While not directly impacted, the compensation structure for directors can reflect the company's overall approach to executive and board incentives.

Next Steps

• The stock options will vest 100% on June 5, 2026, or the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the grant date, whichever is earlier.
• The options will become fully vested if a 'change in control' of Nkarta, Inc. occurs or upon the Reporting Person's separation from service due to death or 'disability'.

Key Dates

Keywords

Nkarta Inc., NKTX, Stock Options, Director Compensation, Insider Transaction, SEC Form 4, Equity Grant, Vesting Schedule, Corporate Governance